Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 2020; 8: e21—In this Correspondence, reference 4 has been removed from the end of the sentence “The expression of ACE2 is substantially increased in patients with type 1 or type 2 diabetes, who are treated with ACE inhibitors and angiotensin II type-I receptor blockers (ARBs).” This correction has been made to the online version as of May 18, 2020.
. 2020 May 18;8(6):e54. doi: 10.1016/S2213-2600(20)30235-6
Correction to Lancet Respir Med 2020; 8: e21
Issue date 2020 Jun.
© 2020 Elsevier Ltd. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC7234787 PMID: 32437647
This corrects the article "Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?" on page e21.